Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Sales (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Return on Sales data on record, last reported at 0.74% in Q4 2025.

  • For Q4 2025, Return on Sales rose 48.0% year-over-year to 0.74%; the TTM value through Dec 2025 reached 0.87%, up 15.0%, while the annual FY2025 figure was 0.87%, 15.0% up from the prior year.
  • Return on Sales reached 0.74% in Q4 2025 per TLSI's latest filing, up from 0.93% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.27% in Q3 2023 and bottomed at 13.75% in Q4 2022.
  • Average Return on Sales over 4 years is 2.6%, with a median of 1.13% recorded in 2025.
  • Peak YoY movement for Return on Sales: soared 751bps in 2023, then crashed -61bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 13.75% in 2022, then surged by 55bps to 6.24% in 2023, then skyrocketed by 80bps to 1.22% in 2024, then skyrocketed by 40bps to 0.74% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.74% in Q4 2025, 0.93% in Q3 2025, and 0.74% in Q2 2025.